Chemical Structure (Abiraterone Acetate Tablets 1)
Abiraterone Tablet
Product Images NDC 0143-9597
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone (NDC 0143-9597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Abiraterone Acetate Tablets 2)
This text is not available.*
Figure 2 (Abiraterone Acetate Tablets 3)
Figure 3 (Abiraterone Acetate Tablets 4)
Abiraterone-250mg-bl (Abiraterone Acetate Tablets 5)
Abiraterone Acetate Tablets 6
Abiraterone Acetate Tablets, USP is a medication that comes in 120 tablets and each tablet contains 250mg of abiraterone acetate. The tablets should not be crushed or chewed and should be swallowed whole. The complete dosage information is included in the accompanying product literature. The product should be stored at temperatures ranging from 20°C to 25°C, with excursions allowed within the range of 15°C to 30°C. It is advised to keep the medication in a light-resistant container with a child-resistant closure. Abiraterone Acetate Tablets, USP is manufactured by The Arab Pharmaceuticals Manufacturing Company in Jordan and distributed by West-Ward Pharmaceuticals Corp. of Eatontown, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
